Tuesday, December 18, 2018

Erasca Picks Up $42M For Cancer Drugs

San Diego-based Erasca, a biopharmaceuticals startup which says it intends to develop oncology drugs to not just treat, but cure, cancer, has raised $42M in a Series A funding round. The funding was led by City Hill Ventures and Cormorant Asset Management, along other, un-named institutional and individual investors. Erasca was founded by Jonathan E. Lim

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.

---